Arş. Gör. ARİF AKYILDIZ
Ana Sayfa
Eğitim Bilgileri
Araştırma Alanları
Akademik İdari Deneyim
Yayınlar & Eserler
Proje & Patent & Tasarım
Bilimsel & Mesleki Faaliyetler
Başarılar & Tanınırlık
Duyurular & Dokümanlar
İletişim
Özgeçmiş Dosyası İndir
Türkçe
English
Hacettepe Üniversitesi
Akademik Veri Yönetim Sistemi
English
Akademik Veri Yönetim Sistemi
English
Yayınlar & Eserler
Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
AKYILDIZ A.
,
GÜVEN D. C.
,
KÖKSAL B.
,
KARAOĞLAN B. B.
,
Kivrak D.
,
Ismayilov R.
, et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
, sa.9, ss.4991-4999, 2024 (SCI-Expanded)
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
ŞAHİN T. K.
,
AKYILDIZ A.
,
DOĞAN O. T.
,
KAVGACI G.
,
GÜVEN D. C.
,
AKSOY S.
PHARMACEUTICALS
, sa.7, 2024 (SCI-Expanded)
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group
AKYILDIZ A.
,
GÜLTEKİN M.
,
YİĞİT E.
,
Demir E.
,
Ismayilov R.
,
AHMED M. A.
, et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, 2024 (SCI-Expanded)
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab
YILDIRIM H. Ç.
,
Anik H.
,
ATEŞ ÖZDEMİR D.
,
Ismayilov R.
,
AKYILDIZ A.
,
ÇAYIRÖZ K.
, et al.
BIOMOLECULES AND BIOMEDICINE
, sa.4, ss.998-1003, 2024 (SCI-Expanded)
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
AKYILDIZ A.
,
Ismayilov R.
,
Rustamova N.
,
Tokatli M.
,
KOÇ İ.
,
AKIN S.
, et al.
Annals of Hematology
, cilt.103, sa.3, ss.905-915, 2024 (SCI-Expanded)
Sirolimus experience in adult patients with vascular malformations
AKYILDIZ A.
,
Ismayilov R.
,
GÜVEN D. C.
,
YILDIRIM H. Ç.
,
Tatar O. D.
,
KUŞ F.
, et al.
Vascular
, 2024 (SCI-Expanded)
A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology
YILDIRIM H. Ç.
,
GÜVEN D. C.
,
AKYILDIZ A.
,
YALÇIN Ş.
,
DİZDAR Ö.
Irish Journal of Medical Science
, cilt.192, sa.6, ss.2631-2634, 2023 (SCI-Expanded)
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
AKYILDIZ A.
,
GÜVEN D. C.
,
Ozluk A. A.
,
Ismayilov R.
,
Mutlu E.
,
Unal O. U.
, et al.
Medicine
, cilt.102, sa.45, 2023 (SCI-Expanded)
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer
YILDIRIM H. Ç.
,
Ismayilov R.
,
AKYILDIZ A.
,
GÜVEN D. C.
,
Abdurrahimli N.
,
DİZDAR Ö.
, et al.
Anti-cancer drugs
, cilt.34, sa.10, ss.1190-1192, 2023 (SCI-Expanded)
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
Ünal Ç.
,
AZİZY A.
,
KARABULUT S.
,
TAŞTEKİN D.
,
AKYILDIZ A.
,
YAŞAR S.
, et al.
The oncologist
, cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded)
Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort
AKYILDIZ A.
,
GÜVEN D. C.
,
YILDIRIM H. Ç.
,
Ismayilov R.
,
YILMAZ F.
,
Tatar O. D.
, et al.
Medicine (United States)
, cilt.102, sa.18, 2023 (SCI-Expanded)
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer
KUŞ F.
,
Guven D. C.
,
YILDIRIM H. Ç.
,
Chalabiyev E.
,
AKYILDIZ A.
,
Tatar O. D.
, et al.
Biomarkers in Medicine
, cilt.17, sa.7, ss.379-389, 2023 (SCI-Expanded)
Emerging treatment strategies in hepatobiliary cancer
GÜVEN D. C.
,
YILDIRIM H. Ç.
,
Chalabiyev E.
,
KUŞ F.
,
YILMAZ F.
,
YAŞAR S.
, et al.
Expert Review of Anticancer Therapy
, cilt.23, sa.3, ss.243-256, 2023 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Unal C.
,
Selcuk N. A.
,
Biricik F. S.
,
Alan O.
,
Ordu C.
,
Selvi O.
, et al.
Eurasian Journal of Medicine and Oncology
, cilt.7, sa.3, ss.232-242, 2023 (ESCI)
Prognostic Value of Androgen Receptor Expression in Premenopausal Women with Estrogen Receptor-Positive Breast Cancer
YILDIRIM H. Ç.
,
ÜNER M.
,
Yildiran Özmen T.
,
Chalabiyev E.
,
GÜVEN D. C.
,
KUŞ F.
, et al.
Journal of Oncological Science
, cilt.9, sa.1, ss.33-37, 2023 (Scopus)
Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review
YILDIRIM H. Ç.
,
AKYILDIZ A.
,
Ismayilov R.
,
Demirok N.
,
BENLİ B. S.
,
Guven D. C.
, et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
, cilt.15, sa.4, ss.307-310, 2022 (ESCI)
Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant Chemotherapy
YILDIRIM H. Ç.
,
Güven D. C.
,
Chalabiyev E.
,
Taban H.
,
YILMAZ F.
,
YAŞAR S.
, et al.
Journal of Oncological Science
, cilt.8, sa.3, ss.143-147, 2022 (Scopus)
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG)
Akyildiz A.
,
GÜLTEKİN M.
,
Yigit E.
,
Demir E.
,
Ismayilov R.
,
AHMED M. A.
, et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).
Akyildiz A.
,
Guven D. C.
,
Koksal B.
,
Karaoglan B. B.
,
Salim D. K.
,
Sutcuoglu O.
, et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024
Metrikler
Daha fazla metrik
Yayın
19
Açık Erişim
6
BM Sürdürülebilir Kalkınma Amaçları